Cisco Systems Inc. gave some more details on the timing of revenue from its anticipated orders related to artificial intelligence, and it looks like...
Shares in Coinbase Global soared Friday after the cryptocurrency broker’s fourth-quarter results comfortably beat Wall Street’s expectations. The company’s earnings also tell a story...
Amer Sports Inc., the Finnish sportswear company that went public last week, on Tuesday launched an offering of $600 million worth of seven-year high-yield...
OBSERVATIONS FROM THE FINTECH SNARK TANK Prediction: By the end of this decade, bank-fintech partnerships will be a thing of the past. This prediction...
During a challenging year for startups and financial institutions, these entrepreneurs, traders and investors are navigating tough terrain and making an outsized impact. By...
In the last three years, the banking and fintech sectors have undergone significant, foundational changes, profoundly impacting U.S. small businesses. Much of the talk...
The King is dead, long live the king. On Tuesday, November 21, Binance, what was the world’s largest cryptocurrency exchange, and the CEO, Changpeng...
XRP As Ripple’s XRP coin continues its upward rally, the crypto community is abuzz with speculation about its future trajectory. Currently priced at $0.6200,...
Source: Pixabay / petre_barlea JPMorgan analysts have reported that the Grayscale Bitcoin Trust (GBTC) could experience outflows of at least $2.7 billion if it...
This article was written by Lawrence Fuller has been managing portfolios for individual investors for 30 years, starting his career at Merrill Lynch in...
By Maximilian Heath BUENOS AIRES (Reuters) – Argentina’s grains trade is largely “paralyzed” by a lack of soybeans due to drought and farmers holding...
Source: AFP Atletico Madrid, the renowned Spanish football club, is suing Singapore-based crypto exchange WhaleFin, following the unexpected termination of its $44 million shirt...
Deals and Financings Beijing’s BeiGene (BGNE; HK: 06160; SHA: 688235) acquired global rights to a preclinical novel cyclin-dependent kinase 2 (CDK2) inhibitor from Boston’s...